Literature DB >> 8239612

Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes.

G Raponi1, M C Ghezzi, C Mancini, F Filadoro.   

Abstract

The release of tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) by human monocytes stimulated with whole heat-killed Candida albicans CA3 (a clinical isolate) and CA2 (a germ tube-negative mutant) either treated or not treated with amphotericin B was investigated. The optimal release of the cytokines was observed at 24 h of incubation of the yeasts with the monocytes for both TNF-alpha and IL-6. The levels ranged from 10,500 to 19,000 U/ml for TNF-alpha and from 350 to 460 pg/ml for IL-6. Germ tube-negative mutant CA2 induced the release of TNF-alpha at levels significantly (P < 0.05) lower than those induced by clinical isolate CA3, while no major differences were observed between the two strains with regard to their capacity to induce the release of IL-6. In all instances, preincubation of the yeasts with a sublethal concentration of amphotericin significantly reduced cytokine production. These results suggest that drug-induced alterations of fungal outer structures may affect the interactions between the yeasts and the monocytes, resulting in a reduced level of secretion of cytokines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239612      PMCID: PMC188099          DOI: 10.1128/AAC.37.9.1958

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

3.  Chemical and antigenic alterations of Candida albicans cell walls related to the action of amphotericin B sub-inhibitory doses.

Authors:  T Al-Bassam; D Poulain; P Giummelly; J Lematre; R Bonaly
Journal:  J Antimicrob Chemother       Date:  1985-03       Impact factor: 5.790

4.  Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes.

Authors:  J Y Djeu; D K Blanchard; A L Richards; H Friedman
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils.

Authors:  E M Johnson; D W Warnock; M D Richardson; C J Douglas
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

6.  Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.

Authors:  J W Van t Wout; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

7.  Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro.

Authors:  R D Diamond; C C Haudenschild
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice.

Authors:  S Steinshamn; A Waage
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils.

Authors:  K E Schuit
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

10.  Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.

Authors:  E Brummer; C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more
  4 in total

Review 1.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

2.  In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms.

Authors:  C E Walters; E Ingham; E A Eady; J H Cove; J N Kearney; W J Cunliffe
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

3.  Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro.

Authors:  M R Yeaman; P M Sullam; P F Dazin; M A Ghannoum; J E Edwards; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 4.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.